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  In human placenta, embryo-derived trophoblasts aggressively invade maternal spiral 4 
arteries and transform the arteries to low-resistant large-caliber vessels.  This process that 5 
ensures adequate placental perfusion is called maternal vascular remodeling.  Histological 6 
examination showed deposition of maternal platelets in the trophoblast aggregates formed in 7 
the spiral arteries.  Several lines of evidence suggest that these platelets are activated.  8 
Soluble factors released from the activated platelets, as whole, enhanced invasive capacity of 9 
isolated trophoblasts in vitro.  These findings suggest importance of non-hemostatic platelet 10 
function in maternal vascular remodeling.  In contrast, gene knockout studies suggest that 11 
maternal platelet defects are compatible with successful pregnancy in mice.  Moreover, 12 
pregnant women with severe platelet defects usually fulfill uneventful pregnancy.  Thus, 13 
promotion of endovascular trophoblast infiltration by maternal platelets might not be the only 14 
mechanism that regulates maternal vascular remodeling. 15 
  The maternal vascular remodeling is an essential component of human reproduction and 16 
should be secured by several complementary mechanisms.  Future studies should aim to 17 
elucidate other mechanisms that could regulate endovascular trophoblast infiltration. 18 
19 




  In human placenta, cytotrophoblasts show two distinct patterns of differentiation (Figure 1).  3 
In floating villi, cytotrophoblasts differentiate into syncytiotrophoblast and form the syncytial 4 
layer, where exchange of gas and nutrients takes place.  On the other hand, at 5 
villus-anchoring sites, cytotrophoblasts differentiate into extravillous trophoblasts and form 6 
the stratified structure called cell column.  After losing proliferative activity and acquiring 7 
invasive activity in the cell column 
1
, extravillous trophoblasts begin to invade decidual tissue 8 
(interstitial trophoblasts) or maternal blood vessels (endovascular trophoblasts). 9 
  Endovascular trophoblasts destroy the muscular linings and replace the endothelium of the 10 
maternal spiral arteries, transforming them from small resistant vessels to flaccid large-caliber 11 
vessels.  This process is called maternal vascular remodeling.  The maternal vascular 12 
remodeling ensures adequate placental perfusion and contributes to establishment of 13 
successful pregnancy 
2
.  In fact, endovascular trophoblast invasion is limited to superficial 14 
decidua and the myometrial segments remain narrow in cases of preeclampsia and/or 15 
intrauterine growth restriction 
3
. 16 
  Vascular infiltration by endovascular trophoblast is a unique phenomenon in primate 17 
placenta 
4
.  Moreover, in most of non-human primates, vascular remodeling is restricted to 18 
the decidua, which in human has to be considered as pathological.  Lack of proper 19 
experimental model animal has hampered analysis of endovascular trophoblast invasion and 20 
the mechanism is still largely unknown. 21 
22 
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Platelet in human placentation 1 
 2 
  What directs extravillous trophoblasts towards the maternal spiral arteries?  It is intuitive 3 
to consider that some factor(s) derived from the endothelium or blood constituents direct this 4 
movement.  Relatively high oxygen tension in maternal arteries promotes trophoblast 5 
differentiation toward invasive phenotype, which could be one of the mechanisms that 6 
facilitate endovascular trophoblast invasion 
5
.  This hypothesis is derived from the findings 7 
that isolated cytotrophoblasts cultured under hypoxic conditions (2% O2) continued 8 
proliferating, whereas those cultured in 20% O2 stopped proliferating and differentiated to 9 
invasive phenotype.  Another candidate that facilitates endovascular trophoblast invasion 10 
could be maternal platelets 
6
.  Histological examination of human placental bed revealed that 11 
maternal platelets are trapped by endovascular trophoblast aggregates that are formed inside 12 
the lumen of the spiral arteries.  These platelets were attached to collagen deposited around 13 
endovascular trophoblasts, suggesting that these platelets are activated.  Indeed, these 14 
platelets expressed P-selectin.  P-selectin is one of activation markers of platelets that binds 15 
to P-selectin glycoprotein ligand-1 (PSGL-1) on the surface of neutrophils, leading to 16 
recruitment and activation of the neutrophils.  The activated neutrophils, in turn, release 17 
platelet-activating factor (PAF) that promotes platelet aggregation 
7
.  In vitro, co-culturing 18 
with platelets that were activated by collagen induced matrigel invasion of extravillous 19 
trophoblasts isolated from early human placental tissue.  After 48-hour culture, most of the 20 
isolated extravillous trophoblasts exhibit elongated spindle-shaped morphology mimicking 21 
interstitial trophoblasts, whereas they are transformed to round-shaped morphology 22 
mimicking endovascular trophoblasts after 48-hour co-culture with platelets (Figure 2).  The 23 
round-shaped cells share similar molecular property with endovascular trophoblasts in vivo, 24 
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such as up-regulation of integrin 1 and CCR1 8 9.  These changes do not require direct 1 
contact of platelets and isolated extravillous trophoblasts, suggesting that some soluble 2 
factor(s) derived from the activated maternal platelets direct trophoblast invasion towards 3 
maternal arteries and induce differentiation towards endovascular phenotype. 4 
  Then, what are the platelet-derived soluble factors that enhance trophoblast invasion?  5 
Besides regulating hemostasis, platelets contain a number of bioactive peptides, including 6 
growth factors (EGF, VEGF, PDGF-B, TGF-1, IGF-1, HGF, bFGF), cytokines (soluble 7 
CD40 ligand), chemokines (RANTES, TG, PF4), and bioactive phospholipids (S1P).  8 
These mediators are stored in platelet granules and released upon stimulation 
10
.  The effect 9 
of platelet-conditioned medium to promote invasion of the isolated extravillous trophoblasts 10 
was completely abrogated by heat treatment, but not by charcoal stripping 
9
.  This suggests 11 
that some growth factors, cytokines, or chemokines, but not bioactive phospholipids 12 
contribute to the invasion-promoting effect of platelets.  Immunocytochemistry revealed that 13 
isolated extravillous trophoblasts express a chemokine receptor, CCR1.  Matrigel invasion 14 
assay revealed that RANTES, one of CCR1 ligands, enhances invasion of isolated 15 
extravillous trophoblasts, indicating that CCR1 expressed on isolated extravillous trophoblasts 16 
is a functional receptor.  Interestingly, immunohistochemisry of the placental bed showed 17 
that CCR1 is predominantly expressed from the cell column through endovascular 18 
trophoblasts.  These findings suggest that circulating maternal platelets are trapped by 19 
endovascular trophoblast aggregates and activated to release CCR1 ligands, which in turn 20 
attracts CCR1-positive extravillous trophoblasts into maternal spiral arteries to encourage the 21 
vascular remodeling (Figure 3).  22 
  In this theory, activation of platelets in the spiral arteries requires the preexistence of 23 
endovascular trophoblast aggregates.  In this respect, platelet is not a primary initiator of 24 
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extravillous trophoblast invasion into the spiral arteries; rather it might provide a positive 1 
feedback mechanism that facilitates endovascular trophoblast infiltration. 2 
3 
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Platelet in mouse placentation 1 
 2 
  Gene knockout has generated several mice lineages that have quantitative or qualitative 3 
platelet defect.  The transcription factor NF-E2 is essential for megakaryopoiesis and 4 




.  NF-E2-null murine 5 
embryos are able to complete intrauterine life, although they show significant growth 6 
restriction at birth.  The growth restriction is associated with abnormal vascularization of the 7 
labyrinthine layer in NF-E2-null placenta.  Since the number of blood vessels in the 8 
labyrinthine layer is not reduced, abnormal vascularization is considered to be due to failure 9 
in the maturation of preexisting vessels.  These indicate that embryonic platelets are required 10 
for normal placentation 
13
.   11 
  In mice lacking -subunit of the heterotrimeric guanine nucleotide binding protein Gq 12 
(Gq), platelet count is normal but these platelets cannot be activated in vitro with 13 
physiological agonists including thrombin, ADP, and collagen 
14
.  In contrast to NF-E2 null 14 
mice, vascularization of Gq-null placenta is not affected, suggesting that hemostatic platelet 15 
function is not required for normal placentation.  In other words, non-hemostatic function of 16 
platelets, which is only revealed in mice with quantitative platelet defect, is essential for the 17 
maturation of the fetus-derived vessels in the placenta 
13
. 18 
  Both quantitatively and qualitatively platelet-deficient mice are able to complete 19 
intrauterine development and some of them even survive to reproductive age.  These adult 20 
female mice allow analysis of possible effects of maternal platelet defect on placentation.  In 21 
contrast to NF-E2 null embryos, the litter size of NF-E2 null mothers is not reduced as long as 22 
embryo has normal platelet count.  Detailed analysis of the placental histology showed that 23 
massive placental hemorrhage occurs in approximately half of the placentas of NF-E2 null 24 
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mothers most probably due to maternal bleeding diathesis 
15
.  Thus, maternal platelet is not 1 
required for normal murine placentation. 2 
 3 
4 
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Platelet and human pathological pregnancies 1 
 2 
  Primary hemostasis begins immediately after endothelial disruption.  The exposed 3 
subendothelial collagen recruits circulating von-Willebrand factor, which binds to platelet 4 
surface glycoprotein Ib-IX-V complex and thus mediates the contact between collagen and 5 
platelets.  Collagen-activated platelets form pseudopods that stretch out to cover the injured 6 
surface and express receptors for fibrinogen that mediates primary platelet aggregation.  7 
Next, bioactive substances such as thromboxane A2 are released from the activated platelets 8 
(platelet degranulation) and further activate surrounding platelets.  These activated platelets 9 
express glycoprotein IIb-IIIa complex that can bind to von-Willebrand factor.  Secondary 10 
platelet aggregation is mediated by interaction between von-Willebrand factor and 11 
glycoprotein IIb-IIIa complex, leading to primary thrombus formation.  In the secondary 12 
hemostasis, coagulation cascade efficiently progresses on the phospholipid exposed on the 13 
surface of the aggregated platelets to solidify the primary thrombus (secondary thrombus 14 
formation). 15 
 Low-dose aspirin has been used worldwide to prevent placenta-mediated obstetric 16 
complications such as recurrent pregnancy loss, intrauterine growth restriction, and 17 
preeclampsia 
16
.  Aspirin inhibits platelet cyclooxygenase to suppress synthesis of 18 
thromboxane A2 that induces secondary platelet aggregation and systemic vasoconstriction.  19 
Thus, theoretically, aspirin can inhibit thrombus formation in the placenta to help maintain 20 
placental blood flow as well as ameliorate hypertension in preeclampsia.  In fact, recent 21 
meta-analysis established moderate but consistent preventative effect of low-dose aspirin 22 
therapy on preeclampsia 
17
.  Since aspirin does not interfere with platelet adhesion to 23 
collagen or subsequent platelet degranulation, platelet release of bioactive soluble factors 24 
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other than thromboxane A2 should be maintained during low-dose aspirin therapy.  1 
Therefore, in terms of maternal vascular remodeling, aspirin does no harm to endovascular 2 
trophoblast invasion enhanced by platelet-derived soluble factors. 3 
  Secondary thrombus formation generally ensues after platelet activation.  Given that 4 
maternal platelets trapped by the endovascular trophoblasts are activated, it seems peculiar 5 
that no fibrin deposition is detected among the endovascular trophoblast aggregates.  6 
Although the actual mechanism for this discrepancy remains to be elucidated, abundant 7 
thrombomodulin 
18






 expressed by 8 
trophoblasts could inhibit the coagulation cascade and/or facilitate rapid degradation of the 9 
fibrin at the surface of the endovascular trophoblasts.  In pathological pregnancies such as 10 
preeclampsia, it is fascinating to consider that inhibitory mechanism against the secondary 11 
thrombus formation around the endovascular trophoblasts is defective, thus leading to 12 
excessive placental thrombosis.  In this situation, aspirin could be particularly beneficial, 13 
because it can inhibit platelet secondary aggregation that triggers the initiation of the 14 
coagulation cascade without affecting endovascular trophoblast invasion. 15 
  Bernard-Soulier syndrome is characterized by deficiency of platelet glycoprotein Ib-IX-V 16 
complex that mediates contact of platelets with collagen 
22
.  In this pathological condition, 17 
collagen-activation of platelets is severely impaired and most of the patients exhibit 18 
spontaneous bruising, epistaxis, and bleeding after minor trauma.  In pregnancy, entrapment 19 
of maternal platelets by collagen-deposited endovascular trophoblasts and the subsequent 20 
activation should be restricted, resulting in insufficient maternal vascular remodeling.  21 
However, pregnant women with Bernard-Soulier syndrome as well as those with congenital 22 
thrombocytopenia generally complete uneventful pregnancy despite an increased risk of 23 
postpartum hemorrhage 
23-25
.  This suggests that maternal platelets are not an essential 24 
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component of human placentation process including maternal vascular remodeling.  1 
Although in vitro data suggest importance of maternal platelets in endovascular trophoblast 2 
infiltration, their actual role in vivo still needs to be defined. 3 
4 
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Conclusion and future direction 1 
 2 
  In human placenta, maternal platelets are deposited in trophoblast clusters that have 3 
invaded the uterine spiral arteries.  These platelets are likely to be activated and release 4 
various soluble factors, which as whole enhance invasive capacity of extravillous trophoblasts 5 
in vitro.  Thus, maternal platelets might be a candidate that attracts extravillous trophoblasts 6 
into the spiral arteries and encourages maternal vascular remodeling.  As demonstrated in 7 
gene-knockout mice with quantitative or qualitative platelet defects, however, maternal 8 
platelets are not required for murine placentation.  The fact that pregnant women with severe 9 
platelet defects are compatible with uneventful pregnancy suggests that maternal platelets are 10 
not an essential component of human placentation. 11 
  The maternal vascular remodeling that ensures adequate placental perfusion is an essential 12 
component of human reproduction and should be secured by several complementary 13 
mechanisms.  In this respect, promotion of endovascular trophoblast infiltration by maternal 14 
platelets could be one of the mechanisms that regulate the vascular remodeling, although the 15 
vascular remodeling might occur in the absence of maternal platelets. 16 
  Precise characterization of endovascular trophoblasts, which is a crucial step for 17 
clarification of the mechanism(s) of maternal vascular remodeling, has been hampered by the 18 
extreme difficulty in their isolation from human placenta.  As mentioned above, co-culture 19 
with platelets could induce differentiation of isolated extravillous trophoblasts towards 20 
endovascular phenotype in vitro.  These endovascular-like trophoblasts are potentially useful 21 
to characterize endovascular trophoblasts, leading to identification of novel mechanisms of 22 
maternal vascular remodeling. 23 
24 
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Figure legend 1 
 2 
Figure 1  Schematic representation of early human placenta. 3 
  In floating villus, cytotrophoblasts (light gray cells) differentiate into multinucleated 4 
syncytiotrophoblast (dark gray cells) and form the syncytial layer, where exchange of gas and 5 
nutrients takes place. At villus-anchoring sites, cytotrophoblasts differentiate into extravillous 6 
trophoblasts (spotted cells) and form the stratified structure called cell column.  Extravillous 7 
trophoblasts acquire invasive activity in the cell column and begin to invade the decidual 8 
tissue (interstitial trophoblasts) or the spiral arteries (endovascular trophoblasts). 9 
 10 
Figure 2  Platelet-derived soluble factors induce endovascular differentiation of isolated 11 
human extravillous trophoblasts. 12 
  Isolated human extravillous trophoblats were cultured for 48 hours in the absence (A, 13 
control) or in the presence of human platelets (B, platelet co-culture) that were plated in the 14 
collagen type I-coated upper chamber.  Note that most of extravillous trophoblasts exhibit 15 
round-shaped morphology (arrows) mimicking endovascular trophoblasts after platelet 16 
co-culture (B). 17 
 18 
Figure 3  An illustration showing possible chemokine gradient produced by platelets in 19 
spiral arteries and its estimated effects on endovascular trophoblast infiltration. 20 
  In the spiral artery undergoing vascular remodeling, platelets are deposited among the 21 
endovascular trophoblasts. These platelets are likely to have been activated by extracellular 22 
matrix secreted from endovascular trophoblasts and to have released various soluble factors 23 
including CCR1 ligands, forming local chemokine gradient.  The chemokine gradient directs 24 
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CCR1-positive extavillous trophoblasts into the spiral artery, providing a positive feedback 1 
cascade for trophoblastic arterial infiltration.  Note that CCR1 is expressed from the cell 2 
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